Targeting amyloid β42 aggregation using a structurally defined graphene quantum dot model: A combined molecular and biological investigation

International Journal of Biological Macromolecules | Vol. 321 | Issue 146205 | 2025

DOI: https://doi.org/10.1016/j.ijbiomac.2025.146205

The novel Bruton tyrosine kinase inhibitor branebrutinib abrogates lipopolysaccharide/galactosamine-induced hepatic injury via limiting inflammation and oxidative stress

Biomedicine & Pharmacotherapy | Vol. 191 | Issue 118462 | 2025

DOI: https://doi.org/10.1016/j.biopha.2025.118462

Design and construction of novel pyridine-pyrimidine hybrids as selective COX-2 suppressors: anti-inflammatory potential, ulcerogenic profile, molecular modeling and ADME/Tox studies

J Biomol Struct Dyn. | Vol. 43 | Issue 4 | 2025

DOI: https://doi.org/10.1080/07391102.2023.2293257

Piperidine: A Versatile Heterocyclic Ring for Developing Monoamine Oxidase Inhibitors

ACS Omega | Vol. 8 | Issue 41 | 2023

DOI: https://doi.org/10.1021/acsomega.3c05883

Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis

Front Pharmacol. | Vol. 14 | 2023

DOI: https://doi.org/10.3389/fphar.2023.1239025

Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib

Front Pharmacol. | 2023

DOI: https://doi.org/10.3389/fphar.2023.1212771

Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities

Int Immunopharmacol | 2023

DOI: https://doi.org/10.1016/j.intimp.2023.110373

The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro, and in silico mechanistic investigations

J Biomol Struct Dyn. | Vol. 41 | Issue 21 | 2023

DOI: https://doi.org/10.1080/07391102.2023.2167000